Navigation Links
Schering-Plough Expands Vicriviroc Phase II Study in Treatment-Naive Patients With HIV
Date:7/15/2009

stigator for the study. "A class-sparing vicriviroc regimen for initial treatment could potentially expand options for patients by offering a new first-line therapy, while having the additional benefit of preserving the current first-line therapy and subsequent regimens for future use."

In the study, the virologic benefit of vicriviroc administered once-daily as a single 30 mg tablet in combination with ritonavir-boosted atazanavir(2) is being compared to a control group receiving Truvada (emtricitabine and tenofovir disoproxil fumarate)(3) plus ritonavir-boosted atazanavir, which is a currently recommended option for first-line therapy. Atazanavir is a product in the protease inhibitor (PI) class of HIV medications. Truvada is a combination product in the nucleoside(tide) reverse transcriptase inhibitor (NRTI) class.

The standard of care for treatment-naive HIV-infected individuals is to combine three drugs from two classes to initiate antiretroviral therapy. The combinations characteristically use two NRTIs with either a non-nucleoside reverse transcriptase inhibitor (NNRTI) or a ritonavir-boosted PI.(4) While these combinations have been demonstrated to be highly effective, long-term tolerance may be limited by the toxicity specifically associated with nucleosides, which can include neuropathy, myopathy, renal toxicity, hepatic steatosis, lactic acidosis, bone marrow suppression, fat atrophy and, with certain agents, increased risk of myocardial infarction.(5-7)

About the Phase II Naive Study

This randomized, controlled, open-label study is projected to enroll approximately 200 treatment-naive HIV-infected adult patients at more than 35 sites in North America, Central America, Europe and South Africa. Patients coinfected with hepatitis B or C may be included in the study.

The primary efficacy endpoint of the study is the mean change from ba
'/>"/>

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Schering-Plough Highlights Hepatitis C Clinical Data Presentations at the European Association for the Study of the Liver (EASL) Annual Meeting
2. Schering-Plough Announces Results of the Early ACS Trial
3. Schering-Ploughs Investigational Oral Thrombin Receptor Antagonist Meets Primary Endpoint in a Newly Published Study
4. Schering-Plough Highlights R&D Pipeline Progress, Innovation and Breadth of Research Projects
5. Schering-Plough Provides Update on Boceprevir Clinical Development and Introduces Potent Next-Generation Oral HCV Protease Inhibitor for Treating Patients With Chronic Hepatitis C
6. Schering-Plough Unveils Top-Line Study Results for SAPHRIS(TM) (asenapine) Demonstrating Efficacy in Long-Term Schizophrenia Relapse Prevention
7. Schering-Plough Reports Preladenant Meets Primary Endpoint in Phase II Dose-Finding Trial for Parkinsons Disease
8. Schering-Plough Announces European Launch of BRIDION(R) (Sugammadex)
9. Schering-Plough Announces Phase III Data for Sustained Follicle Stimulant
10. About 60 Clinical Studies Regarding Schering-Ploughs Oncology Compounds Will be Presented at ASCO
11. Schering-Plough To Initiate Phase III Studies With HCV Protease Inhibitor Boceprevir in Previously Untreated Hepatitis C Patients and Those Who Failed Prior Treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/15/2009)... 15 OrthoWorx, the newly formed industry, community ... device sector in Kosciusko County, is working to connect ... like Chicago and Cleveland via high-speed rail. ,, In ... The Orthopedics Capital of the World -- An ... growth, BioCrossroads, the statewide initiative to grow ...
(Date:12/15/2009)... Dakim, Inc. and Alzheimer,s Weekly today announced ... Brain Health Contest, designed to help five seniors in ... Alzheimer,s disease. All five winners will receive a $2,500 ... help seniors preserve their brain health and the most ... communities across the country. ,, The contest, ...
(Date:12/15/2009)... Dec. 15 Medical researchers with EDP ... their revolutionary new technology for a simple blood ... ,, Following the success of its pre-clinical trials ... patent on the biomarker, CA11-19, and all aspects ... test, ColoMarker(TM) will detect colon cancer in its ...
Breaking Medicine Technology:OrthoWorx Urges Warsaw's Inclusion on High-Speed Rail Corridor Connecting Chicago and Cleveland 2OrthoWorx Urges Warsaw's Inclusion on High-Speed Rail Corridor Connecting Chicago and Cleveland 35 Seniors Win $2,500 Dakim BrainFitness System to Fight Alzheimer's 25 Seniors Win $2,500 Dakim BrainFitness System to Fight Alzheimer's 3Researchers Announce Medical Breakthrough with Simple, Inexpensive Blood Test for Colon Cancer 221st International Radon Symposium 57111 121st International Radon Symposium 57111 2eClinicalWorks Utilizes EMC to Manage Business Expansion and Reduce Costs 57108 1eClinicalWorks Utilizes EMC to Manage Business Expansion and Reduce Costs 57108 2eClinicalWorks Utilizes EMC to Manage Business Expansion and Reduce Costs 57108 3JEWEL OSCO PHARMACY Offers Grocery Savings to Flu Shot Customers 57105 1JEWEL OSCO PHARMACY Offers Grocery Savings to Flu Shot Customers 57105 2
... Collaborative Research Agreement With The University of Texas M. D., ... ... Cancer, VEDBAEK, Denmark, May ... today,announces that it has signed a collaborative research agreement with the,Kleberg Center ...
... and Only Treatment for Hunter Syndrome Now Approved in 40 ... ... Worldwide, BASINGSTOKE, England and CAMBRIDGE, Massachusetts, May 27, ... announced that ELAPRASE(R),(idursulfase), a human enzyme replacement therapy for the ...
Other Medicine Technology:Exiqon Forms Research Collaboration With M. D. Anderson Cancer Center 2Exiqon Forms Research Collaboration With M. D. Anderson Cancer Center 3Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 2Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 3Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 4Shire Announces Approval of ELAPRASE(R) (idursulfase) in Brazil 5
(Date:12/15/2009)... decade, the United Nations Foundation has led the fight ... World Malaria Report 2009 that the global strategies for ending malaria ... Health for the United Nations Foundation , ... Washington, ... United Nations Foundation has led the fight against malaria, ...
(Date:12/15/2009)... developmental changes increases risk in teens, study suggests , , ... overweight or obese increases the risk of obstructive sleep ... true for younger children, Australian researchers have found. , ... 2 to 18, who were referred for evaluation of ... that among those aged 12 and older the risk ...
(Date:12/15/2009)... Program, a new employment opportunity for the unemployed or those needing ... opportunities in America today. , ... Orlando, FL (PRWEB) ... successful collection agencies, is spreading holiday cheer and good will that ... RPS has created an opportunity for out of work Americans to ...
(Date:12/15/2009)... injury when doctors decide benefits of imaging outweigh the ... scans can pose a serious risk to people with ... Administration researchers exposed pacemakers to a simulated MRI magnetic ... the tip of the pacemaker lead, where it would ... exposure to MRI magnetic pulses caused certain pacemakers to ...
(Date:12/15/2009)... a surgical method, with fewer complications, analysis finds, , , ... to diagnosing breast cancer, women and their doctors have ... invasive "core needle biopsy" procedure is nearly as effective ... is, with fewer complications than the surgical version. , ... 5 issue of Annals of Internal Medicine , ...
Breaking Medicine News(10 mins):Health News:Statement by Dr. Daniel Carucci, Vice President for Global Health for the United Nations Foundation, on Progress Shown in World Malaria Report 2009 2Health News:Puberty May Trigger Sleep Apnea in Overweight Kids 2Health News:RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away 2Health News:RPS Worldwide Launches Affiliate Program -- The Collection Agency That Gives Christmas Back, Rather Than Take it Away 3Health News:Patients With Pacemakers Should Avoid MRI Scans 2Health News:Needle Biopsy Works Well in Diagnosing Breast Cancer 2
... SANTA CRUZ, Calif., Sept. 19 The ShirleyBOARD ... Web Marketing,Association (WMA) for Outstanding Achievement in Website ... of Excellence WebAward,Designation. ShirleyBOARD is a free ... caring for aging loved ones stay organized and ...
... 19 The Coalition for,Fairness in Mental Illness Coverage ... Mental Health Parity Act of 2007, setting the stage ... because of the,leadership of Senators Pete V. Domenici (R-NM), ... will make mental health and substance use,disorder insurance coverage ...
... HealthDATA, the industry,s,only end-to-end resource for comprehensive market ... completed the updates to their Long Term,Care and ... updated,information about the facilities and their corporate parents, ... number of overall contacts compared to,the prior year. ...
... Mass., Sept. 19 Hologic, Inc.,(Nasdaq: HOLX ) ... presenting at the UBS Global Life Sciences Conference being ... Hotel in New York, NY. Interested parties are ... investor presentation on Wednesday, September 26, 2007 at 4:30,p.m. ...
... with Oxford Journals, and the Japanese Society of Medical ... which will result in ESMOs official journal Annals of ... society. , Annals of Oncology is fully owned by ... the journal will be endorsed by JSMO and all ...
... living with cancer or have survived it, one factor ... communication. In recognition of this, the National Cancer Institute ... co-authored by a University of Rochester physician, stating that ... and deserves more research. , Without the ability to ...
Other Medicine News:Health News:Elder Caregiving Site ShirleyBOARD.com Wins WebAward for Outstanding Online Community 2Health News:Billian's HealthDATA Completes Comprehensive Long Term Care Database Update 2Health News:ESMO, Oxford Journals and the Japanese Society of Medical Oncology announce collaboration 2Health News:Communication in cancer world is key to survival 2
Incontinence Pessaries...
Indications: for young women who experience stress urinary incontinence when excercising vigorously; i.e., aerobics, tennis, jogging....
... pessary is designed for third ... well as a cystocele and ... available both with and without ... silicone tie to aid in ...
The Mar-Land is used for stress incontinence and minor prolapse. It is available both with and without support in seven different sizes....
Medicine Products: